Regeneron Pharmaceuticals: Filings
Current report8-KSep 30, 2026—
Current report8-KJun 17, 2026—
Proxy statementDEF 14AApr 24, 2026FY2025
Annual report10-KFeb 4, 2026FY2025
Current report8-KJun 18, 2025—
Proxy statementDEF 14AApr 29, 2025FY2024
Annual report10-KFeb 5, 2025FY2024
Current report8-KJun 20, 2024—
Proxy statementDEF 14AApr 25, 2024FY2023
Annual report10-KFeb 5, 2024FY2023
Current report8-KJan 31, 2024—
Current report8-KSep 8, 2023—
Current report8-KApr 17, 2023—
Annual report10-KFeb 6, 2023FY2022
Annual report10-KFeb 7, 2022FY2021
Annual report10-KFeb 8, 2021FY2020
Annual report10-KFeb 7, 2020FY2019
Annual report10-KFeb 7, 2019FY2018
Annual report10-KFeb 8, 2018FY2017
Annual report10-KFeb 9, 2017FY2016
20 filings